Actively Recruiting
Auricular VNS Following Intracerebral Hemorrhage
Led by Washington University School of Medicine · Updated on 2025-07-15
80
Participants Needed
1
Research Sites
357 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
CONDITIONS
Official Title
Auricular VNS Following Intracerebral Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients who present with a spontaneous supratentorial intracerebral hemorrhage (ICH) to Barnes Jewish Hospital
You will not qualify if you...
- Patients younger than 18 years old
- Patients with traumatic cause of ICH, infratentorial hemorrhage, ICH volume greater than 60 ml or less than 10 ml
- Patients at risk of imminent death (e.g., Glasgow Coma Scale of 3 or unreactive pupils)
- Patients with planned surgical intervention (excluding ventriculostomy)
- Patients undergoing active cancer therapy
- Patients with sustained bradycardia on arrival with heart rate less than 50 beats per minute
- Patients who cannot be enrolled within 48 hours of the initial bleed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
R
Raj Dhar, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here